Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Clover HealthCLOV |
-$111M |
 |
MetLifeMET |
-$96M |
 |
AflacAFL |
-$242M |
 |
ProgressivePGR |
-$2.01B |
 |
Root InsuranceROOT |
-$705M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Burdick Kenneth A | Dec 4, 2025 | Sell | 32,796 | $39 | $1.3M |
| Burdick Kenneth A | Dec 3, 2025 | Sell | 33,211 | $39.04 | $1.3M |
| LONDON SARAH | Aug 8, 2025 | Buy | 19,230 | $25.5 | $490,000 |
| Samuels Theodore R. II | Jul 28, 2025 | Buy | 9,000 | $27.62 | $250,000 |
| Greco Thomas | Dec 18, 2024 | Buy | 17,000 | $59.75 | $1M |
| Dallas H James | Dec 16, 2024 | Buy | 1,693 | $59.01 | $100,000 |
| BLUME JESSICA L. | Dec 16, 2024 | Buy | 250 | $59.48 | $15,000 |
| COUGHLIN CHRISTOPHER J | Dec 16, 2024 | Buy | 10,000 | $59.44 | $590,000 |
| Samuels Theodore R. II | Dec 13, 2024 | Buy | 5,000 | $58.86 | $290,000 |
| Asher Andrew Lynn | Nov 13, 2024 | Buy | 17,200 | $58.14 | $1M |
| LONDON SARAH | Nov 8, 2024 | Buy | 4,117 | $60.8 | $250,000 |
| COUGHLIN CHRISTOPHER J | May 14, 2024 | Sell | 878 | $76.745 | $67,000 |
| FASOLA KENNETH J | May 13, 2024 | Sell | 8,000 | $77.62 | $620,000 |
| Robinson Lori Jean | Feb 13, 2024 | Sell | 10,000 | $77.41 | $770,000 |
| FASOLA KENNETH J | Feb 7, 2024 | Sell | 8,190 | $74.83 | $610,000 |
| FASOLA KENNETH J | Feb 7, 2024 | Sell | 3,810 | $75.58 | $290,000 |
FAQ - Insider Transactions
The most recent insider transaction for Centene was conducted by Burdick Kenneth A, who sold 32,796 shares on December 4, 2025 at a price of $39.00 per share.
Greco Thomas has bought the most CNC stock in the last 2 years, with a total value of $1M.
Burdick Kenneth A has sold the most CNC stock in the last 2 years, with a total value of $2.6M.
The total value of insider transactions for Centene in the last 2 years is negative, amounting to -$930,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Centene have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
